JP2025501630A5 - - Google Patents
Info
- Publication number
- JP2025501630A5 JP2025501630A5 JP2024538682A JP2024538682A JP2025501630A5 JP 2025501630 A5 JP2025501630 A5 JP 2025501630A5 JP 2024538682 A JP2024538682 A JP 2024538682A JP 2024538682 A JP2024538682 A JP 2024538682A JP 2025501630 A5 JP2025501630 A5 JP 2025501630A5
- Authority
- JP
- Japan
- Prior art keywords
- alkylene
- heterocycloalkyl
- cycloalkyl
- hydrogen
- heteroaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2021904274A AU2021904274A0 (en) | 2021-12-24 | Compounds | |
| AU2021904274 | 2021-12-24 | ||
| PCT/AU2022/051593 WO2023115167A1 (en) | 2021-12-24 | 2022-12-23 | Compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025501630A JP2025501630A (ja) | 2025-01-22 |
| JP2025501630A5 true JP2025501630A5 (enExample) | 2026-01-07 |
Family
ID=86900852
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024538674A Pending JP2025501629A (ja) | 2021-12-24 | 2022-12-23 | 化合物 |
| JP2024538682A Pending JP2025501630A (ja) | 2021-12-24 | 2022-12-23 | 化合物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024538674A Pending JP2025501629A (ja) | 2021-12-24 | 2022-12-23 | 化合物 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20250101038A1 (enExample) |
| EP (2) | EP4452937A4 (enExample) |
| JP (2) | JP2025501629A (enExample) |
| CN (2) | CN118696029A (enExample) |
| CA (2) | CA3244229A1 (enExample) |
| WO (2) | WO2023115167A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3519816A4 (en) | 2016-09-29 | 2020-05-06 | The Regents of the University of California | CONNECTIONS FOR INCREASING NEURONAL PLASTICITY |
| KR102946120B1 (ko) | 2019-02-27 | 2026-03-30 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 뇌 장애를 치료하기 위한 아제피노-인돌 및 다른 헤테로사이클 |
| WO2021226416A1 (en) | 2020-05-08 | 2021-11-11 | Psilera Inc. | Novel compositions of matter and pharmaceutical compositions |
| EP4396162A4 (en) | 2021-09-03 | 2025-11-12 | Alexander Shulgin Res Institute Inc | ASYMMETRIC ALLYL TRYPTAMINES |
| IL313455A (en) | 2021-12-15 | 2024-08-01 | Delix Therapeutics Inc | Phenoxy and benzyloxy modified psychroplastogens and their uses |
| WO2023129956A2 (en) | 2021-12-30 | 2023-07-06 | ATAI Life Sciences AG | Dimethyltryptamine analogues as nitric oxide delivery drugs |
| EP4525860A2 (en) * | 2022-05-20 | 2025-03-26 | Caamtech, Inc. | Tryptamine derivatives |
| IL318840A (en) * | 2022-08-11 | 2025-04-01 | Gilgamesh Pharmaceuticals Inc | Tryptamines and methods of treating mood disorders |
| KR20250053871A (ko) * | 2022-08-31 | 2025-04-22 | 사이빈 아이알엘 리미티드 | 트립타민 화합물, 조성물, 및 사용 방법 |
| WO2025052388A1 (en) * | 2023-09-07 | 2025-03-13 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Psychedelic compounds, methods of their preparation and uses thereof |
| WO2025137581A1 (en) * | 2023-12-21 | 2025-06-26 | Atai Therapeutics, Inc. | Novel tetrahydro pyridine substituted indole and azaindoles, compositions of matter and pharmaceutical compositions |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1928892A (en) * | 1991-06-21 | 1993-01-25 | Smithkline Beecham Plc | Tryptamine analogues, their synthesis and their use as 5-ht1-like or 5-ht2 receptor agonists |
| GB9718833D0 (en) * | 1997-09-04 | 1997-11-12 | Merck Sharp & Dohme | Therapeutic agents |
| CA2353962C (en) * | 1998-12-11 | 2009-09-29 | Virginia Commonwealth University | Selective 5-ht6 receptor ligands |
| SI1379239T1 (sl) * | 2001-03-29 | 2008-02-29 | Lilly Co Eli | N-(2-ariletil)benzilamini, uporabljeni kot antagonisti receptorja 5-ht6 |
| AU2003242245A1 (en) * | 2002-06-12 | 2003-12-31 | Sumitomo Pharmaceuticals Co., Ltd. | Indole, indazole, and benzazole derivative |
| US7645886B2 (en) * | 2002-12-20 | 2010-01-12 | Ciba Specialty Corporation | Synthesis of amines and intermediates for the synthesis thereof |
| US7994196B2 (en) * | 2004-02-12 | 2011-08-09 | Mitsubishi Tanabe Pharma Corporation | Indazole compound and pharmaceutical use thereof |
| US7655691B2 (en) * | 2004-09-27 | 2010-02-02 | Sard Howard P | Indole compounds useful as serotonin selective agents |
| WO2007046112A1 (en) * | 2005-10-19 | 2007-04-26 | Suven Life Sciences Inc. | Arylthioether tryptamine derivatives as functional 5-ht6 ligands |
| WO2008046155A1 (en) * | 2006-10-20 | 2008-04-24 | Dia-B Tech Limited | Methods for regulating glucose homeostasis and agents therefor |
| AU2009214724A1 (en) * | 2008-02-11 | 2009-08-20 | Organix Inc. | Indole compounds and methods of use thereof |
| TW201018695A (en) * | 2008-07-30 | 2010-05-16 | Ferrer Int | 1,6-dihydro-2H-3-oxa-6-aza-as-indacene compounds |
| US8349898B2 (en) * | 2008-11-18 | 2013-01-08 | Wisconsin Alumni Research Foundation | Sigma-1 receptor ligands and methods of use |
| EP2464227A4 (en) * | 2009-08-10 | 2013-02-20 | Galenea Corp | COMPOUNDS AND METHODS OF USE |
| CN102219725B (zh) * | 2010-04-16 | 2013-10-09 | 中国科学院上海药物研究所 | 苯并杂环类化合物及其制备方法和用途 |
| AU2012212323A1 (en) * | 2011-02-01 | 2013-09-12 | The Board Of Trustees Of The University Of Illinois | HDAC inhibitors and therapeutic methods using the same |
| KR20260008838A (ko) * | 2020-02-18 | 2026-01-16 | 길가메쉬 파마슈티컬스, 인코포레이티드 | 기분 장애 치료에 사용되기 위한 특이적 트립타민 |
| US20230140635A1 (en) * | 2020-03-12 | 2023-05-04 | Bright Minds Biosciences Inc. | 3-(2-(Aminoethyl)-Indol-4-ol Derivatives, Methods of Preparation Thereof, and the Use as 5-HT2 Receptor Modulators |
| WO2021234608A1 (en) * | 2020-05-19 | 2021-11-25 | Cybin Irl Limited | Deuterated tryptamine derivatives and methods of use |
| CN115867532A (zh) * | 2020-06-12 | 2023-03-28 | 弗特克斯药品有限公司 | Apol1的抑制剂及其用途 |
| JP2024520485A (ja) * | 2021-05-26 | 2024-05-24 | ブライト マインズ バイオサイエンスィズ インコーポレイテッド | 複素環式化合物及びその調製方法 |
-
2022
- 2022-12-23 WO PCT/AU2022/051593 patent/WO2023115167A1/en not_active Ceased
- 2022-12-23 WO PCT/AU2022/051592 patent/WO2023115166A1/en not_active Ceased
- 2022-12-23 CA CA3244229A patent/CA3244229A1/en active Pending
- 2022-12-23 US US18/723,719 patent/US20250101038A1/en active Pending
- 2022-12-23 CN CN202280091811.XA patent/CN118696029A/zh active Pending
- 2022-12-23 EP EP22908928.9A patent/EP4452937A4/en active Pending
- 2022-12-23 US US18/723,836 patent/US20250074873A1/en active Pending
- 2022-12-23 JP JP2024538674A patent/JP2025501629A/ja active Pending
- 2022-12-23 CA CA3244224A patent/CA3244224A1/en active Pending
- 2022-12-23 CN CN202280091813.9A patent/CN118715204A/zh active Pending
- 2022-12-23 EP EP22908929.7A patent/EP4452938A4/en active Pending
- 2022-12-23 JP JP2024538682A patent/JP2025501630A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025501630A5 (enExample) | ||
| JP2025501629A5 (enExample) | ||
| JP2025501141A5 (enExample) | ||
| IL295371A (en) | Psilocyin derivatives as serotonergic psychedelics for the treatment of central nervous system disorders | |
| JP2023513679A5 (enExample) | ||
| JP2023512821A5 (enExample) | ||
| JP6839104B2 (ja) | ウイルス感染の治療及び予防のための新規な置換アミノチアゾロピリミジンジオン | |
| ES2729630T3 (es) | Compuestos heteroaromáticos y su uso como ligandos de dopamina D1 | |
| RU2018115569A (ru) | Оксаспиропроизводное, способ его получения и его применения в лекарственных средствах | |
| AU2022201929A1 (en) | Inhibitors of (alpha-v)(beta-6) integrin | |
| JP5969993B2 (ja) | 式（Ｉ）のｐａｎ−ＣＤＫ阻害剤の調製のための方法、および該調製における中間体 | |
| CN111171047B (zh) | 用于治疗cns障碍的稠合二氢-4h-吡唑并[5,1-c][1,4]噁嗪基化合物 | |
| JP2020517711A (ja) | ２−アミノ−キノリン誘導体 | |
| EP3519816A1 (en) | Compounds for increasing neural plasticity | |
| JP2019505541A5 (enExample) | ||
| JP2024508922A5 (enExample) | ||
| CA2683887A1 (en) | Aminodihydrothiazine derivatives substituted with a cyclic group having inhibitory activity against production of amyloid beta protein | |
| CN115038697A (zh) | 治疗剂和治疗方法 | |
| CA2783258A1 (en) | Pteridinones as inhibitors of polo-like kinase | |
| JP2020502092A5 (enExample) | ||
| JP2023553094A5 (enExample) | ||
| JP2017536399A5 (enExample) | ||
| RU2012128583A (ru) | 3,6-диазабицикло[3.1.1]гептаны в качестве лигандов нейрональных никотиновых ацетилхолиновых рецепторов | |
| TR201901074T4 (tr) | MGlu2 reseptörlerinin negatif allosterik modülatörleri olarak 6,7-dihidropirazolo[1,5-a]pirazin-4(5h)-on bileşikleri ve bunların kullanımı. | |
| JP2019535747A5 (enExample) |